OKYO Insider Trading (OKYO Pharma)
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £354,679.73
Insider Selling (Last 12 Months): GBX 0
OKYO Pharma Share Price & Price History
Current Price: GBX 2.75
Price Change: +0.30 (1.20%)
As of 08/12/2022 01:00 AM ET
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.
And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
OKYO Pharma Insider Trading History
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|6/8/2022||Willy Jules Simon||Insider||Buy||55,991||GBX 3||£1,679.73|
|5/19/2022||Gabriele Cerrone||Insider||Buy||5,800,000||GBX 6||£348,000|
|1/26/2022||Gabriele Cerrone||Insider||Buy||100,000||GBX 5||£5,000|
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.
SEC Filings (Institutional Ownership Changes) for OKYO Pharma (LON:OKYO)
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. It is developing OK-101 for the treatment of dry eye disease; and OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. The company is also developing chemerin and chemerin analogues to treat the cytokine release syndrome associated with COVID-19 infections and other conditions, such as acute respiratory distress syndrome. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
Now: GBX 2.75
50 Day Range
MA: GBX 2.77
52 Week Range
Now: GBX 2.75
Who are the company insiders with the largest holdings of OKYO Pharma?